Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Molecular Pharmaceutics
|
August 24, 2017
Biorelevant Dissolution Models for a Weak Base To Facilitate Formulation Development and Overcome Reduced Bioavailability Caused by Hypochlordyria or Achlorhydria
Dawen Kou, Sudharsan Dwaraknath, Yannick Fischer, et al.
Radiology Case Reports
|
September 28, 2018
Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
Paul C Lyon, Helen Winter, Karin Herbschleb, et al.
Cancers
|
December 5, 2019
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
Helen Winter, Pamela J Kaisaki, Joe Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics
Laurent Claret, Jin Y Jin, Charles Ferté, et al.
Lancet (London, England)
|
July 26, 2012
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, et al.
Clinical and Translational Science
|
November 12, 2025
Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants
Jack Chang, Aryun Kim, Rita Humeniuk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2020
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer Patients
Elliot M Abbott, Nadia Falzone, Boon Q Lee, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis
Andreas H Diacon, Rodney Dawson, Florian Von Groote-Bidlingmaier, et al.
Clinical and Translational Science
|
September 9, 2023
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
Rita Humeniuk, Kavita Juneja, Shuguang Chen, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent
Chi-Chi Peng, Rita Humeniuk, Anuja Raut, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Molecular Pharmaceutics
|
August 24, 2017
Biorelevant Dissolution Models for a Weak Base To Facilitate Formulation Development and Overcome Reduced Bioavailability Caused by Hypochlordyria or Achlorhydria
Dawen Kou, Sudharsan Dwaraknath, Yannick Fischer, et al.
Radiology Case Reports
|
September 28, 2018
Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
Paul C Lyon, Helen Winter, Karin Herbschleb, et al.
Cancers
|
December 5, 2019
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
Helen Winter, Pamela J Kaisaki, Joe Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics
Laurent Claret, Jin Y Jin, Charles Ferté, et al.
Lancet (London, England)
|
July 26, 2012
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, et al.
Clinical and Translational Science
|
November 12, 2025
Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants
Jack Chang, Aryun Kim, Rita Humeniuk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2020
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer Patients
Elliot M Abbott, Nadia Falzone, Boon Q Lee, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis
Andreas H Diacon, Rodney Dawson, Florian Von Groote-Bidlingmaier, et al.
Clinical and Translational Science
|
September 9, 2023
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
Rita Humeniuk, Kavita Juneja, Shuguang Chen, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent
Chi-Chi Peng, Rita Humeniuk, Anuja Raut, et al.
Page
of 5